Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Valneva, Andritz (16/10/2020)

18.10.2020

Valneva: Valneva, a French-Austrian specialty vaccine company focused on prevention of diseases with major unmet needs, today announced that the European Medicines Agency (EMA) has granted PRIority MEdicines (PRIME) designation for its single-shot Phase 3 chikungunya vaccine candidate VLA1553. This new designation from the EMA complements the Fast Track designation received by the U.S. Food and Drug Administration (FDA) in December 2018. The PRIME designation is awarded by the EMA to promising medicines that demonstrate the potential to address substantial unmet medical need based on initial clinical data. The EMA considers PRIME designations a priority and provides medicine developers with special support, including enhanced interactions and dialogue, as well as a pathway for accelerated evaluation and review.
Valneva: weekly performance: -2.12%

Andritz: International technology Group Andritz has received an order from Segezha Pulp and Paper Mill, a member of the Segezha Group (part of PJSC Sistema), to supply stock preparation equipment for its mill in Segezha, Republic of Karelia, Russia. Start-up is scheduled for the beginning of 2021. The new system will feature a capacity of 350 bdmt/d and process bleached market pulp bales to produce a new final product – white high-porosity sack paper. The scope of supply comprises the bale feeding line with a manual dewiring station, an Andritz FibreSolve FSV pulper for efficient slushing, a ModuScreen CP protection screen, as well as the complete control and electrification system.
Andritz: weekly performance: 2.12%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/10/2020)


Partners









latest 21st Austria

21st Austria weekly - Valneva, Andritz (16/10/2020)


18.10.2020, 1668 Zeichen



Valneva: Valneva, a French-Austrian specialty vaccine company focused on prevention of diseases with major unmet needs, today announced that the European Medicines Agency (EMA) has granted PRIority MEdicines (PRIME) designation for its single-shot Phase 3 chikungunya vaccine candidate VLA1553. This new designation from the EMA complements the Fast Track designation received by the U.S. Food and Drug Administration (FDA) in December 2018. The PRIME designation is awarded by the EMA to promising medicines that demonstrate the potential to address substantial unmet medical need based on initial clinical data. The EMA considers PRIME designations a priority and provides medicine developers with special support, including enhanced interactions and dialogue, as well as a pathway for accelerated evaluation and review.
Valneva: weekly performance: -2.12%

Andritz: International technology Group Andritz has received an order from Segezha Pulp and Paper Mill, a member of the Segezha Group (part of PJSC Sistema), to supply stock preparation equipment for its mill in Segezha, Republic of Karelia, Russia. Start-up is scheduled for the beginning of 2021. The new system will feature a capacity of 350 bdmt/d and process bleached market pulp bales to produce a new final product – white high-porosity sack paper. The scope of supply comprises the bale feeding line with a manual dewiring station, an Andritz FibreSolve FSV pulper for efficient slushing, a ModuScreen CP protection screen, as well as the complete control and electrification system.
Andritz: weekly performance: 2.12%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/10/2020)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1217: ATX unchanged, AT&S top, die 40-Prozent-Woche bei Bajaj und ich trag im Herzen drin ein Stückerl altes Wien




 

Bildnachweis

Aktien auf dem Radar:Bajaj Mobility AG, Rosenbauer, Andritz, Semperit, EuroTeleSites AG, Flughafen Wien, Porr, SBO, Athos Immobilien, Marinomed Biotech, Österreichische Post, Wolftank-Adisa, BTV AG, BKS Bank Stamm, Kapsch TrafficCom, Amag, DO&CO, CPI Europe AG, Telekom Austria, UBM, SAP, Henkel, Symrise, Bayer, Fresenius Medical Care, BASF, Deutsche Boerse, Fresenius, Hannover Rück, DAIMLER TRUCK HLD..., Rheinmetall.


Random Partner

Raiffeisen Zertifikate
Raiffeisen Zertifikate ist der führende österreichische Anbieter, der mit über 5.000 Anlage- und Hebelprodukten seit mehr als 20 Jahren in der DACH-Region genauso wie in vielen Märkten Zentral- und Osteuropas zu Hause ist. Einfach kompetent und schnell Marktentwicklungen handelbar zu machen, dafür steht Raiffeisen Zertifikate - Egal ob auf Aktien, Aktien-Indizes, Rohstoffe oder einzelne Themen basierend. Raiffeisen Zertifikate ist eine Marke der Raiffeisen Bank International AG.

>> Besuchen Sie 55 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten